Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases.

O'Brien KL, Santosham M.

Am J Epidemiol. 2004 Apr 1;159(7):634-44. Review.

PMID:
15033641
2.

Pneumococcal conjugate vaccine for young children.

Selman S, Hayes D, Perin LA, Hayes WS.

Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Review.

3.

[New pneumococcal vaccine].

Gaudelus J.

Bull Acad Natl Med. 2003;187(8):1477-86; discussion 1486-8. Review. French.

PMID:
15146579
4.

Pneumococcal conjugate vaccine.

Ledwith M.

Curr Opin Pediatr. 2001 Feb;13(1):70-4. Review.

PMID:
11176248
5.

A new conjugate vaccine against pneumococcal disease.

Wilson-Adkins M, Adkins C.

Nurse Pract. 2001 May;26(5):52, 55-6, 59-62. Review.

PMID:
11383494
6.
7.

The potential of pneumococcal conjugate vaccines for children.

Whitney CG, Pickering LK.

Pediatr Infect Dis J. 2002 Oct;21(10):961-70. Review.

PMID:
12394822
8.

Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine.

Dinleyici EC, Yargic ZA.

Expert Rev Vaccines. 2009 Aug;8(8):977-86. doi: 10.1586/erv.09.68. Review.

PMID:
19627181
9.

Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.

Zangeneh TT, Baracco G, Al-Tawfiq JA.

Expert Rev Vaccines. 2011 Mar;10(3):345-53. doi: 10.1586/erv.11.1. Review.

PMID:
21434802
10.

The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.

Toltzis P, Jacobs MR.

Infect Dis Clin North Am. 2005 Sep;19(3):629-45. Review.

PMID:
16102653
11.

The pneumococcal conjugate vaccine.

Jacobson RM, Poland GA.

Minerva Pediatr. 2002 Aug;54(4):295-303. Review.

PMID:
12131865
12.

The potential indirect effect of conjugate pneumococcal vaccines.

O'Brien KL, Dagan R.

Vaccine. 2003 May 16;21(17-18):1815-25. Review.

PMID:
12706665
13.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
14.

[Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].

de Arístegui Fernández J, Corretger Rauet JM, García Martín F, Hernández-Sampelayo T, Moraga Llop FA, Rodrigo Gonzalo De Liria C, Ruiz Contreras J; Comité Asesor deVacunas de la Asociación Española de Pediatría.

An Esp Pediatr. 2002 Jan;56(1):79-90. Review. Spanish.

PMID:
11792258
15.

Pneumococcal disease in United States children: prevalence and treatment.

Clanton M.

Int J Clin Pract Suppl. 2001 Feb;(118):13-21. Review.

PMID:
11715359
16.

Conjugate pneumococcal vaccines for aboriginal children in Australia.

Torzillo PJ, Gratten M.

Med J Aust. 2000 Oct 2;173 Suppl:S51-3. Review.

PMID:
11062809
17.

The safety of 7-valent pneumococcal conjugate vaccine.

Ghaffar F.

Expert Opin Drug Saf. 2005 Jul;4(4):631-6. Review.

PMID:
16011442
18.

Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases.

Bricks LF, Berezin E.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S67-74. Epub 2006 May 19. Review.

19.

Conjugate pneumococcal vaccines: an overview.

Mulholland EK.

Med J Aust. 2000 Oct 2;173 Suppl:S48-50. Review.

PMID:
11062808
20.

Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA.

Tan TQ.

Expert Rev Anti Infect Ther. 2010 Feb;8(2):117-25. doi: 10.1586/eri.09.132. Review.

PMID:
20109042

Supplemental Content

Support Center